Search - Université de Rennes Access content directly

Filter your results

28 Results
Author: personID (integer) : 765692

Accurate Classification of Germinal Center B-Cell-Like/Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase-Multiplex Ligation-Dependent Probe Amplification Assay: A CALYM Study.

Sylvain Mareschal , Philippe Ruminy , Cristina Bagacean , Vinciane Marchand , Marie Cornic et al.
Journal of Molecular Diagnostics, 2015, 17 (3), pp.273-283. ⟨10.1016/j.jmoldx.2015.01.007⟩
Journal articles hal-01145953v1

Recurrent Mutations of the Exportin 1 Gene (XPO1) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study.

Fabrice Jardin , Anaïs Pujals , Laura Pelletier , Elodie Bohers , Vincent Camus et al.
57th ASH Annual Meeting and Exposition, Dec 2015, Orlando, Floride, United States
Conference papers hal-02481340v1

Targeting netrin-1/DCC interaction in diffuse large B-cell and mantle cell lymphomas

Laura Broutier , Marion Creveaux , Jonathan Vial , Antonin Tortereau , Jean-Guy Delcros et al.
EMBO Molecular Medicine, 2016, 8 (2), pp.96--104. ⟨10.15252/emmm.201505480⟩
Journal articles hal-01269905v1

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study

Hervé Tilly , Franck Morschhauser , Olivier Casasnovas , Thierry Jo Molina , Pierre Feugier et al.
The Lancet Haematology, 2018, 5 (9), pp.e403-e410. ⟨10.1016/S2352-3026(18)30131-5⟩
Journal articles hal-02329073v1

Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions

Ciara L. Freeman , Franck Morschhauser , Laurie Sehn , Mark Dixon , Richard Houghton et al.
Blood, 2015, 126 (24), pp.2646--2649. ⟨10.1182/blood-2015-09-670802⟩
Journal articles hal-01275480v1

Definition of a minimal genes set for mature lymphoid blood diseases

Pierre Sujobert , Yannick Le Bris , Laurence de Leval , Audrey Gros , Jean Philippe Merlio et al.
Hématologie, 2018, 24 (1), pp.27-59. ⟨10.1684/hma.2018.1315⟩
Journal articles hal-01870189v1
Image document

Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study

Emmanuel Bachy , Jane A. Estell , Eric van De Neste , Reda Bouabdallah , Joan Bargay et al.
American Journal of Hematology, 2016, 91 (4), pp.410-415. ⟨10.1002/ajh.24305⟩
Journal articles hal-01263105v1
Image document

Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group

Christophe Bonnet , Jehan Dupuis , Hervé Tilly , Thierry Lamy , Christophe Fruchart et al.
Cancers, 2022, 14 (7), pp.1761. ⟨10.3390/cancers14071761⟩
Journal articles hal-03660656v1

CD1d-restricted peripheral T cell lymphoma in mice and humans

Emmanuel Bachy , Mirjam Urb , Shilpi Chandra , Rémy Robinot , Gabriel Bricard et al.
Journal of Experimental Medicine, 2016, 213 (5), pp.841-57. ⟨10.1084/jem.20150794⟩
Journal articles hal-01305487v1

Abstract 4810: Exome sequencing of refractory diffuse large B-cell lymphomas highlights candidate genes for targeted resequencing

Sylvain Mareschal , Pierre-Julien Viailly , Philippe Bertrand , Elodie Bohers , Jean-Philippe Jais et al.
AACR 106th Annual Meeting 2015, Apr 2015, Philadelphia, PA, United States. 75 (15 Supplement), pp.4810--4810, 2015, ⟨10.1158/1538-7445.AM2015-4810⟩
Conference poster hal-01300809v1

PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study.

Christelle Tychyj-Pinel , Fabien Ricard , Michael Fulham , Marion Fournier , Michel Meignan et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 (3), pp.408-15
Journal articles hal-01141154v1

T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?

Pierre Raynaud , Sylvie Caulet-Maugendre , Charles Foussard , Gilles Salles , Anne Moreau et al.
Human Pathology, 2008, 39 (2), pp.194-200. ⟨10.1016/j.humpath.2007.05.026⟩
Journal articles istex hal-00678052v1
Image document

Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape

Frédéric Mourcin , Léa Verdière , David Roulois , Rada Amin , Claire Lamaison et al.
Immunity, 2021, 54 (8), pp.1788-1806.e7. ⟨10.1016/j.immuni.2021.05.019⟩
Journal articles hal-03282989v1

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Sydney Dubois , Pierre-Julien Viailly , Elodie Bohers , Philippe Bertrand , Philippe Ruminy et al.
Clinical Cancer Research, 2017, 23 (9), pp.2232-2244. ⟨10.1158/1078-0432.CCR-16-1922⟩
Journal articles hal-01526582v1
Image document

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study.

Mira Tout , Olivier Casasnovas , Michel Meignan , Thierry Lamy , Franck Morschhauser et al.
Blood, 2017, 129 (19), pp.2616-2623. ⟨10.1182/blood-2016-10-744292⟩
Journal articles hal-01547802v1

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill , Catherine Thieblemont , Lucie Oberic , Anne Moreau , Krimo Bouabdallah et al.
New England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
Journal articles hal-02329536v1
Image document

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies

Pierre Sujobert , Yannick Le Bris , Laurence de Leval , Audrey Gros , Jean Philippe Merlio et al.
HemaSphere, 2019, 3 (1), pp.e169. ⟨10.1097/HS9.0000000000000169⟩
Journal articles hal-02397399v1
Image document

Impact of doxorubicin dose capping on the outcome of DLBCL patients with elevated body surface area

Caroline Gay , Richard Delarue , Noël Milpied , Lucie Oberic , Bertrand Coiffier et al.
Blood, 2017, 129 (20), pp.2811-2813. ⟨10.1182/blood-2017-02-766147⟩
Journal articles hal-01558813v1
Image document

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

Franck Morschhauser , Gilles Salles , Steven Le Gouill , Hervé Tilly , Catherine Thieblemont et al.
Blood, 2018, 132 (14), pp.1486 - 1494. ⟨10.1182/blood-2018-05-853499⟩
Journal articles hal-01928199v1
Image document

Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study

Emmanuel Bachy , Roch Houot , Pierre Feugier , Krimo Bouabdallah , Reda Bouabdallah et al.
Blood, 2022, 139 (15), pp.2338-2346. ⟨10.1182/blood.2021013526⟩
Journal articles hal-03679319v1
Image document

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

Emmanuel Bachy , Roch Houot , Franck Morschhauser , Anne Sonet , Pauline Brice et al.
Haematologica, 2013, 98 (7), pp.1107-14. ⟨10.3324/haematol.2012.082412⟩
Journal articles hal-00933219v1
Image document

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Sarah Huet , Bruno Tesson , Jean-Philippe Jais , Andrew Feldman , Laura Magnano et al.
Lancet Oncology, 2018, 19 (4), pp.549 - 561. ⟨10.1016/S1470-2045(18)30102-5⟩
Journal articles hal-01788996v1
Image document

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Élie Azoulay , Pedro Castro , Adel Maamar , Victoria Metaxa , Alice Gallo de Moraes et al.
The Lancet Haematology, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
Journal articles hal-03208127v1

Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma

Sylvain Mareschal , Sydney Dubois , Pierre-Julien Viailly , Philippe Bertrand , Elodie Bohers et al.
Genes, Chromosomes & Cancer, 2016, 55 (3), pp.251-267. ⟨10.1002/gcc.22328⟩
Journal articles istex hal-01237083v1
Image document

Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study

Sydney Dubois , Pierre-Julien Viailly , Sylvain Mareschal , Elodie Bohers , Philippe Bertrand et al.
Clinical Cancer Research, 2016, 22 (12), pp.2919--2928. ⟨10.1158/1078-0432.CCR-15-2305⟩
Journal articles hal-01343064v1

Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants.

Judith Trotman , Marion Fournier , Thierry Lamy , John Francis Seymour , Anne Sonet et al.
Journal of Clinical Oncology, 2011, 29 (23), pp.3194-200. ⟨10.1200/JCO.2011.35.0736⟩
Journal articles hal-00741692v1
Image document

Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma

John Timmerman , Charles Herbaux , Vincent Ribrag , Andrew D. Zelenetz , Roch Houot et al.
American Journal of Hematology, 2020, 95 (5), pp.510-520. ⟨10.1002/ajh.25757⟩
Journal articles hal-02798009v1
Image document

Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study

Franck Morschhauser , Steven Le Gouill , Pierre Feugier , Sarah Bailly , Emmanuelle Nicolas-Virelizier et al.
The Lancet Haematology, 2019, 6 (8), pp.e429-e437. ⟨10.1016/S2352-3026(19)30089-4⟩
Journal articles hal-02586078v1